Stamford, CT -- (SBWIRE) -- 08/20/2013 -- High Rising Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), LeapFrog Enterprises, Inc. (NYSE:LF), Resource Capital Corp.(NYSE:RSO), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) shares gained 0.71% to $4.83. The company on August 14 announced that it has entered into a settlement agreement with Sandoz, Inc. to resolve pending patent litigation in response to Sandoz's abbreviated new drug application (ANDA) seeking approval to market generic versions of Avanir's NUEDEXTA capsules.
Additionally, the company on August 6 said its total net revenues for the quarter ended June 30, 2013 were $19.8 million, compared with $10.5 million for the comparable quarter in fiscal 2012. Net loss for the fiscal 2013 third quarter was $11.4 million, or $0.08 per share, compared with a net loss of $15.0 million, or $0.11 per share, for the same period in fiscal 2012.
Is AVNR A Strong At The CMP? Get Advantage Of Our Free Trend Analysis Here
LeapFrog Enterprises, Inc. (NYSE:LF) shares increased 0.10% to $10.22. The company, on August 1, announced financial results for the second quarter ended June 30, 2013. Second quarter 2013 net sales were $83.0 million, up 16% compared to $71.5 million last year. Net loss (GAAP) for the second quarter was $3.3 million, an improvement of 59% compared to $8.1 million a year ago. Net loss per basic and diluted share (GAAP) was $0.05, an improvement of $0.07, or 58%, compared to $0.12 a year ago.
Is LF A Good Buy After The Recent Price Movement? Find Out Here
Resource Capital Corp.(NYSE:RSO) shares climbed 0.55% to $5.45. The company on August 6 reported results for the three and six months ended June 30, 2013. Adjusted Funds from Operations ("AFFO") for the three and six months ended June 30, 2013 was $19.6 million, or $0.16 per share-diluted and $40.6 million, or $0.36 per share-diluted, respectively. GAAP net income allocable to common shares for the three and six months ended June 30, 2013 was $6.5 million, or $0.05 per share-diluted and $18.1 million, or $0.16 per share-diluted, respectively, as compared to $16.4 million, or $0.20 per share-diluted and $30.9 million, or $0.37 per share-diluted for the three and six months ended June 30, 2012, respectively.
Should Investors Rush To Buy RSO After The Solid Rally? Get Special Report Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares is trading at $3.27. The company on August 8 announced its second quarter 2013 financial results. Net loss for the second quarter of 2013 was $30.3 million, or basic and diluted net loss per share available to common stockholders of $0.31, compared with net loss for the second quarter of 2012 of $20.1 million, or basic and diluted net loss per share available to common stockholders of $0.22. Collaboration revenues for the second quarter of 2013 were $18.5 million, compared to $12.1 million for the second quarter of 2012, an increase of $6.4 million, or 53%.
How Should Investors Trade MACK After The Recent Volatility? Get Free Report Here
High Rising Stocksis always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)